RadNet Inc header image

RadNet Inc

RDNT

Equity

ISIN US7504911022 / Valor 2812237

NASDAQ (2024-11-21)
USD 81.30-1.05%

RadNet Inc
UMushroom community rating:

star star star star star
0.00 0 votes No rating yet
NegativeNeutralPositive

About company

RadNet Inc. is a leading provider of outpatient diagnostic imaging services in the United States, operating over 365 freestanding, fixed-site centers. The company offers a comprehensive range of imaging services, including MRI, CT, PET/CT, mammography, ultrasound, and X-ray. RadNet's IT division, eRAD, specializes in delivering integrated, web-based, cloud solutions designed to streamline medical imaging workflows. Additionally, RadNet Television (RTV) provides targeted programming for patients and their families, enhancing the overall patient experience. The company's extensive network and advanced technological solutions position it as a significant player in the medical imaging industry.

Summarized from source with an LLMView SourceSector: Healthcare

Latest Results (13.06.2024):

Revenue Growth

In the first quarter of 2024, RadNet Inc. reported a significant increase in total company revenue, which rose by 10.5% to $431.7 million from $390.6 million in the first quarter of 2023. This growth was notably driven by the performance of the Digital Health segment, where revenue surged by 32.3% to $14.7 million.

EBITDA Improvement

RadNet Inc. experienced a robust increase in its Adjusted EBITDA(1) for the first quarter of 2024, reaching $58.5 million, up 21.4% from $48.2 million in the same quarter of the previous year. This improvement reflects enhanced operational efficiency and effective cost management across the company.

AI Revenue Surge

The Digital Health segment of RadNet Inc. saw a remarkable increase in AI Revenue, which climbed by 118.8% to $4.7 million in the first quarter of 2024, up from $2.1 million in the first quarter of 2023. This growth highlights the successful expansion and adoption of AI technologies within the company's offerings.

Net Loss Reduction

Despite the revenue and EBITDA gains, RadNet Inc. reported a net loss of $2.8 million in the first quarter of 2024, which, however, was a significant improvement from a net loss of $21.0 million in the first quarter of 2023. The reduction in net loss is indicative of the company's ongoing efforts to streamline operations and reduce costs.

Guidance Revision

Following the strong performance in the first quarter of 2024, RadNet Inc. has revised its full-year guidance upwards, reflecting increased optimism about its revenue, Adjusted EBITDA(1), and Free Cash Flow(2) projections for the year. This revision suggests confidence in the company's continued growth trajectory and operational success.

Summarized from source with an LLMView Source

Key figures

156%1Y
187%3Y
329%5Y

Performance

39.3%1Y
43.3%3Y
56.9%5Y

Volatility

Market cap

6082 M

Market cap (USD)

Daily traded volume (Shares)

117,396

Daily traded volume (Shares)

1 day high/low

82.92 / 81.25

1 day high/low (USD)

52 weeks high/low

0.00 / 0.00

52 weeks high/low (USD)

Dividend ex-date

01 January, 2022

Dividend ex-date

Dividend

0.00

Dividend (USD)

Dividend yield (p.a.)

0.00%

Dividend yield (p.a.)

0.002022
0.002023
0.002024

Est dividend (USD)

0.00%2022
0.00%2023
0.00%2024

Est dividend yield

P/E ratio

10.00

P/E ratio

00.002022
00.002023
00.002024

Est P/E ratio

EPS

0.00

EPS (USD)

0.002022
0.002023
0.002024

Est EPS (USD)

Ratings & reviews

star star star star star

0.00

0 votes
Performance:
starstarstarstarstar
0.00
Innovation:
starstarstarstarstar
0.00
Society:
starstarstarstarstar
0.00
Nature:
starstarstarstarstar
0.00

EQUITIES OF THE SAME SECTOR

Oncopeptides AB
Oncopeptides AB Oncopeptides AB Valor: 35671972
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
1.48%SEK 1.51
QuidelOrtho Corporation
QuidelOrtho Corporation QuidelOrtho Corporation Valor: 119356965
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
1.09%USD 37.89
Zimmer Biomet Holdings Inc
Zimmer Biomet Holdings Inc Zimmer Biomet Holdings Inc Valor: 1262932
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-0.80%USD 108.40
dentalcorp Holdings Ltd
dentalcorp Holdings Ltd dentalcorp Holdings Ltd Valor: 111405816
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-1.18%CAD 9.24
DocMorris Ltd
DocMorris Ltd DocMorris Ltd Valor: 4261528
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-6.11%CHF 28.90
Savaria Corp
Savaria Corp Savaria Corp Valor: 1385257
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
0.80%CAD 22.81
Sienna Senior Living Inc
Sienna Senior Living Inc Sienna Senior Living Inc Valor: 28093100
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
0.24%CAD 17.03
WELL Health Technologies Corp
WELL Health Technologies Corp WELL Health Technologies Corp Valor: 42769021
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
0.58%CAD 5.17
agilon health inc
agilon health inc agilon health inc Valor: 110653729
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
6.59%USD 1.78
Terveystalo Oyj
Terveystalo Oyj Terveystalo Oyj Valor: 37893402
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-1.61%EUR 9.80